PyInvesting

Market research

1011.HK China NT Pharma Group Company Limited

HK HKD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
342M
P/E ratio
Not available
Analyst target
1.3
Dividend yield
Not available
Beta
-2.01

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

China NT Pharma Group Company Limited is currently in a long term downtrend where the price is trading 6.8% below its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.

China NT Pharma Group Company Limited's total revenue sank by 50.3% to $89M since the same quarter in the previous year.

Its net income has increased by 86.0% to $-83M since the same quarter in the previous year.

Finally, its free cash flow grew by 162.8% to $14M since the same quarter in the previous year.

Based on the above factors, China NT Pharma Group Company Limited gets an overall score of 3/5.